Clinical Trial

Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia

Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Summary
This study evaluates the addition of Acipimox or placebo to exercise on growth hormone release and ghrelin secretion in bulimic patients and in healthy women. Two groups of participants will receive Acipimox together with exercise versus identical placebo with exercise.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2017-11-07; most recent amendment 2025-02-16.
Trial Details
NCT Number NCT03338387
Lead Sponsor Charles University, Czech Republic
Conditions Eating Disorder, Bulimia Nervosa
Enrollment 24 participants
Start Date 2003-05-06
Primary Completion 2007-12-16 (estimated)
Study Completion 2026-12-20 (estimated)
Updated on ClinicalTrials.gov 2025-02-19